| Ytd | 9.02% | |
| 1y | 131.13% |
| Open | 14.40 | Prev Close | 14.55 | Low | 13.22 | High | 14.88 | Mkt Cap | 352.52M |
| Vol | 812.16K | Avg Vol | 811.73K | EPS | -1.41 | P/E | N/A | Forward P/E | -1.06 |
| Beta | 2.15 | Short Ratio | 1.46 | Inst. Own | 47.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 12.30 | 200-d Avg | 11.34 | 1yr Est | 16.30 |
Cantor Fitzgerald analyst Olivia Brayer Saunders reiterates Tenax Therapeutics (NASDAQ:TENX) with
Guggenheim analyst Seamus Fernandez maintains Tenax Therapeutics (NASDAQ:TENX) with a Buy and rai
Chardan Capital analyst Gautam Chukka initiates coverage on Tenax Therapeutics (NASDAQ:TENX) with
Piper Sandler analyst Yasmeen Rahimi maintains Tenax Therapeutics (NASDAQ:TENX) with a Overweight